CTXR vs PSX · rev $7.1M vs P/E 17, rev $83.54B
Citius Pharmaceuticals Inc (CTXR) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
CTXR currently screens at market cap $13.4M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the CTXR and PSX stock pages for the full models.
Not investment advice.